How many insider trades does FilingIQ track for CERT?

FilingIQ tracks 399 Form 4 insider transactions for CERT (Certara, Inc.), covering filings from Dec 10, 2020 onwards. 72 of those were filed in the last 90 days.

Are CERT insiders net buyers or net sellers?

Across the full Form 4 history for CERT, 9 transactions (2%) were open-market purchases and 149 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CERT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CERT in?

Certara, Inc. (CERT) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $1.12B.

CERT insider trading

NasdaqGS Healthcare

Certara, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

399

Last 90 days

Buys / sells

2% / 37%

Market cap

$1.12B

About Certara, Inc.

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Company website: www.certara.com

CERT insider activity at a glance

FilingIQ has scored 399 insider transactions for CERT since Dec 10, 2020. The most recent filing in our index is dated May 11, 2026.

Across the full history, 9 open-market purchases and 149 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CERT insider trades is 58.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CERT trades on FilingIQ Raw filings on SEC EDGAR

Latest CERT Form 4 filings

Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF

S Sep 9, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding CERT

Mubadala Investment Co PJSC

$169.13M · 0.6% of AUM

Frequently asked

How many insider trades does FilingIQ track for CERT?: FilingIQ tracks 399 Form 4 insider transactions for CERT (Certara, Inc.), covering filings from Dec 10, 2020 onwards. 72 of those were filed in the last 90 days.
Are CERT insiders net buyers or net sellers?: Across the full Form 4 history for CERT, 9 transactions (2%) were open-market purchases and 149 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CERT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CERT in?: Certara, Inc. (CERT) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $1.12B.

Methodology & sources

Every CERT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.